Kate says cancer is ‘life-changing' for patients and their loved ones
Kate, wearing a brown blazer and brown trousers, said the recovery journey from cancer is a 'rollercoaster' as she discussed treatment and the importance of holistic cancer care with patients, volunteers and staff at Colchester Hospital's Wellbeing Centre on Wednesday.
The princess, who revealed she had been diagnosed with cancer in March last year, praised the centre's 'holistic' approach to the support it offers patients, relatives and carers which includes counselling and dietary advice.
While chatting to a group of the centre's users, volunteers and staff, the princess said: 'You put on a sort of brave face, stoicism through treatment, treatment's done, then it's like 'I can crack on, get back to normal' but actually the phase afterwards is really, you know, difficult you're not necessarily under the clinical team any longer but you're not able to function normally at home as you perhaps once used to and actually someone to help talk you through that, show you and guide you through that sort of phase that comes after treatment I think is really valuable.'
She said: 'It's life changing for anyone, through first diagnosis or post-treatment and things like that, it is life changing experience both for the individual patient but also for the families as well and actually it sometimes goes unrecognised, you don't necessarily, particularly when it's the first time, you don't appreciate how much impact it is going to have.
'You have to find your new normal and that takes time.
'Someone described the sort of healing, recovery journey to me as being like a sort of zig-zag.
'It's a rollercoaster, it's not one smooth plain, which you expect it to be, but the reality is it's not, you go through hard times and to have a place like this, to have the support network, whether its through creativity and singing or gardening, whatever it might be, is so valuable and it's great that this community has it.
'It would be great if lots of communities had this kind of support.'
She added: 'There is this whole phase when you finish your treatment that you, yourself, everybody expects you, right you've finished your time, go, you're better, and that's not the case at all.'
After visiting the centre, the princess braved the drizzly weather to plant several coral-pink Catherine's Rose plants in the hospital's Royal Horticultural Society (RHS) Wellbeing Garden.
The RHS named the flower after Kate to raise awareness of the role that spending time outdoors plays in supporting people's mental, physical and spiritual wellbeing.
Foregoing gardening gloves which were offered to her, she knelt down to plant the roses using her bare hands and a trowel to pat down the soil alongside Adam Frost, the award-winning garden designer who led the design of the space.
Opened in July last year, the wellbeing garden at the hospital offers a relaxing and restorative space for NHS staff, patients and visitors.
Funds from the sale of Catherine's Rose, bred by Harkness Roses, will go to The Royal Marsden Cancer Charity to help the Royal Marsden NHS Foundation Trust establish a training programme for clinical teams across the country to help patients who need intensive support live well with and after cancer.
The princess revealed in January she was in remission from cancer after making an emotional return to the specialist cancer institution, the Royal Marsden Hospital in Chelsea, London, where she was treated.
Some 500 rose plants are being donated by Harkness Roses and Kensington Palace to wellbeing and community gardens across the UK this summer.
In June, the princess was said to have been disappointed as she missed Royal Ascot for the second successive year as she sought the right balance following her treatment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why AstraZeneca Stock Topped the Market on Tuesday
American investors might not have to trade in the company's ADSes in the future. Its CEO is considering a shift in its listing, and even a potential move for its headquarters. 10 stocks we like better than AstraZeneca Plc › Trading in AstraZeneca's (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly liked that idea, as they bid those ADSes up by more than 2% that trading session. With that rise, it did better than the S&P 500 (SNPINDEX: ^GSPC), which closed the day marginally (0.1%) lower. That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company's stock market listing onto our shores (ADSes are certificates conferring ownership of a stock, not the stock itself). Citing unidentified multiple sources, the newspaper wrote that Soriot might also be mulling a move of AstraZeneca's headquarters from the U.K. to the U.S. Currently, the global healthcare company is a component of the FTSE 100, considered by many to be the most important U.K. stock index. According to The Times' reporting, the chief executive is "known to be deeply frustrated with the U.K.'s operating environment." The newspaper added that he has publicly expressed concern about what he perceives to be a decline in European competitiveness against the U.S. and China. The pair happens to be the company's two largest markets. Neither Soriot nor AstraZeneca has yet officially commented on the article. Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the headquarters here. It's unclear (at least for now) how much this might affect the company's fundamentals and operations, but as a concept, it's a good idea. Before you buy stock in AstraZeneca Plc, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and AstraZeneca Plc wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $722,181!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $968,402!* Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy. Why AstraZeneca Stock Topped the Market on Tuesday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Talks on plans for community centre with 'focus on mental health and well-being'
Councillors and police officers have come together at Little Lever Library to discuss plans for a facility, which has been in the works for two years. Dozens gathered to discuss the prospect of a new community centre in Mytham Road. The proposed centre would be open to the public and hopes to house numerous groups, ranging from mental health services to a safe place for youths to visit. The building on Mytham Road will be the proposed site for the hub. (Image: Google maps) Cllr Andrea Taylor-Burke said: 'This project has been going on for around two years using the empty community centre building on Mytham Road. 'I found out that it was a council-owned building and wanted to turn it into a mental health hub and wellness centre for people. "It's been an uphill battle trying to get this off the ground, but I have that fire because I know that this could be really beneficial for the area. READ MORE: 'There are lots of charities and organisations backing this. The community meeting invited councillors, local representatives and police officers. (Image: Bolton GMP) 'I envision it as somewhere people can come, especially young people, to spend time together and chill out, people who don't know where to turn. 'We want to dedicate a space to Marc Palin, who unfortunately took his own life. His story has really resonated with me and stuck with me for years. 'I never met him, but he's always in the back of my mind. I think, if he'd had somewhere to go, if he'd seen this place, he could have gone in there and found someone to chat to. The community meeting invited councillors, local representatives and police officers. (Image: Bolton GMP) 'We're looking at doing events and classes, such as yoga and sound baths, baby groups, that sort of thing. "The focus will be on mental health and well-being but there are no limits to what we can do with the space once we have it. 'We're currently waiting for the building use to go to council planning tender. It's a perfect asset that we've got that we haven't used. A Greater Manchester Police spokesperson said: 'This is a great idea for bringing the community together, whether it's for a brew and a piece of toast or just a chat.' Plans for the site are being considered by the council. The council has been contacted for comment about the plans.


Business Upturn
2 hours ago
- Business Upturn
Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence
Alembic Pharmaceuticals Inc., the wholly owned US subsidiary of Alembic Pharmaceuticals Limited, has announced the acquisition of UK-based Utility Therapeutics Ltd. This strategic move marks Alembic's entry into the branded anti-infective segment in the United States, particularly focusing on treatments for urinary tract infections (UTIs). Utility Therapeutics is engaged in developing pharmaceutical products aimed at combating UTIs, a widespread medical condition in the US. The acquisition brings two key assets into Alembic's fold — 'Pivya,' an FDA-approved treatment for uncomplicated UTIs, and 'MEC,' a pipeline product currently under development to address complicated UTI cases. Alembic Pharmaceuticals sees this acquisition as a significant step towards strengthening its presence in the US market with branded specialty products. The deal allows Alembic to market Utility's assets in the US, leveraging the regulatory approvals already in place and continuing the development of promising pipeline therapies. The total consideration for the acquisition is expected to be around $12 million, paid in a staggered manner depending on the achievement of specific milestones. It also includes a provision for profit sharing based on future earnings generated by Utility's products. The transaction does not fall under the related party category, and none of the promoters or group companies have any financial interest in the deal. Completion of the acquisition is anticipated within approximately 30 days, and no additional regulatory approvals are required. This acquisition aligns with Alembic's strategy of expanding its global footprint and diversifying its product offerings in regulated markets like the US. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at